Carson Advisory’s Gilead Sciences GILD Stock Holding History

Carson Advisory’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$476K	Sell	3,768 -200	-5%	-$26.4K	0.22%	99
2026 Q1	$553K	Hold	3,968	–	–	0.29%	81
2025 Q4	$487K	Buy	3,968 +40	+1%	+$4.86K	0.25%	86
2025 Q3	$436K	Sell	3,928 -200	-5%	-$22.7K	0.24%	87
2025 Q2	$458K	Sell	4,128 -500	-11%	-$53.2K	0.29%	77
2025 Q1	$519K	Hold	4,628	–	–	0.35%	69
2024 Q4	$427K	Sell	4,628 -300	-6%	-$27K	0.3%	77
2024 Q3	$413K	Hold	4,928	–	–	0.26%	97
2024 Q2	$338K	Hold	4,928	–	–	0.24%	104
2024 Q1	$361K	Hold	4,928	–	–	0.25%	101
2023 Q4	$399K	Buy	4,928 +29	+0.6%	+$2.26K	0.31%	92
2023 Q3	$367K	Hold	4,899	–	–	0.32%	93
2023 Q2	$378K	Sell	4,899 -400	-8%	-$31.9K	0.32%	89
2023 Q1	$440K	Sell	5,299 -700	-12%	-$58K	0.39%	77
2022 Q4	$515K	Buy	+5,999	New	+$475K	0.49%	57

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Carson Advisory's GILD Position: Q2 2026 in Review

Carson Advisory reduced its Gilead Sciences (GILD) stake by 5% in Q2 2026, selling an estimated $26.4K and leaving 3,768 shares worth $476K. The position accounts for 0.22% of the portfolio, ranked #99.

Carson Advisory first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $553K in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Carson Advisory held 3,768 shares of Gilead Sciences worth $476K as of Q2 2026.
Carson Advisory sold 200 Gilead Sciences shares in Q2 2026, an estimated $26.4K.
Gilead Sciences made up 0.22% of Carson Advisory's portfolio in Q2 2026, its #99 holding.
Carson Advisory first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
Carson Advisory's Gilead Sciences position peaked at $553K in Q1 2026.
2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Carson Advisory's 13F filing for Q2 2026, filed 11 Aug 2026.